✦ LIBER ✦

OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma

✍ Scribed by Kaufman, Howard L; Bines, Steven D

Book ID: 120803891
Publisher: Future Medicine
Year: 2010
Tongue: English
Weight: 565 KB
Volume: 6
Category: Article
ISSN: 1479-6694
DOI: 10.2217/fon.10.66

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase IB Trial of Intravenous INO-1001

A Phase IB Trial of Intravenous INO-1001 Plus Oral Temozolomide in Subjects with Unresectable Stage-III or IV Melanoma

✍ Bedikian, Agop Y.; Papadopoulos, Nicholas E.; Kim, Kevin B.; Hwu, Wen-Jen; Homsi 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 226 KB

Randomized phase 2/3 trial of CpG oligod

Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma

✍ Jeffrey S. Weber; Hassan Zarour; Bruce Redman; Uwe Trefzer; Steven O'Day; Alfons 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

## Abstract ## BACKGROUND: The primary objective of this phase 2 study was to assess the objective response rate (complete response [CR] + partial responses [PR]), by Response Evaluation Criteria in Solid Tumors, of PF‐3512676, a CpG oligodeoxynucleotide, alone in 2 doses or in combination with da